Atlas Trials

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Clinical trial NCT00740532 · COMPLETED

Trial details

NCT number
NCT00740532
Sponsor
Istituto Clinico Humanitas
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2007-10-01
Primary completion
2008-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.